Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 13, 2025 10:00 ET | Source: AscellaHealth, LLC

AscellaHealth Awarded on the Financial Times Americas’ Fastest Growing Companies 2025 List!

AscellaHealth Awarded on the Financial Times Americas’ Fastest Growing Companies 2025 List!
May 13, 2025 09:43 ET | Source: Applied Pharmaceutical Innovation (API)

Applied Pharmaceutical Innovation Appoints Dr. Launa Aspeslet as Chief Translational Officer to Accelerate Life Sciences Commercialization in Canada

Applied Pharmaceutical Innovation (API) appoints Dr. Launa Aspeslet as Chief Translational Officer to drive life sciences commercialization in Canada.
May 13, 2025 02:30 ET | Source: eleva GmbH

Eleva Appoints Donato Spota as Chief Financial Officer

Freiburg im Breisgau, Germany, May 13, 2025 – Eleva, a pioneer in discovering and developing previously inaccessible biologics based on a breakthrough technology platform, appointed Mr. Donato Spota...
May 12, 2025 09:51 ET | Source: Maxis AI

MaxisIT Evolves to Maxis AI, Launches Enterprise-Ready Agentic AI Platform to Transform Clinical Trials in Pharmaceutical and Life Sciences Industry

MaxisIT rebrands as Maxis AI, unveiling an enterprise-grade Agentic AI platform to accelerate clinical trials through intelligent, compliant automation.
May 08, 2025 14:15 ET | Source: UTR Therapeutics Inc.

UTR Therapeutics Inc Announces IND submission to the US FDA for a First-in-Human Clinical Trial of an mRNA destabilizing drug targeting c-MYC driven cancers

UTR Therapeutics Inc Announces IND submission to the US FDA for a First-in-Human Clinical Trial of an mRNA destabilizing drug targeting c-MYC driven cancer
May 06, 2025 03:00 ET | Source: Priothera

Priothera Appoints Dr. Jens Hasskarl as Chief Medical Officer to Drive Late-Stage Clinical Development of Mocravimod, a S1P Receptor Modulator for Acute Myeloid Leukemia (AML)

Dr. Hasskarl to lead global Phase 3 MO-TRANS study evaluating mocravimod as an adjunctive treatment to allo-HCT in AML Saint-Louis, France and Dublin, Ireland – 6th May 2025– Priothera Ltd., a...
May 06, 2025 02:00 ET | Source: Angelini Ventures

Angelini Ventures Co-Leads $45 Million Series B Financing of Nuevocor to Advance Transformative Treatment for Genetic Dilated Cardiomyopathy

Angelini Ventures marks its first investment in the cardiovascular and gene therapy space – and first in Asia, further diversifying its strong and growing portfolio Rome, Italy - 6 May 2025 –...
April 30, 2025 09:11 ET | Source: HLTH

HLTH 2025 Launches Groundbreaking New Experiences in AI, Pharma, and Diagnostics – While Returning Classics Get a Fresh Twist

HLTH 2025 shines a spotlight on the seismic shifts in the healthcare ecosystem with new, immersive marketplaces and programming.
April 29, 2025 10:03 ET | Source: AscellaHealth, LLC

AscellaHealth Honored as Silver Stevie® Award Winner in 2025 American Business Awards®

AscellaHealth Honored as Silver Stevie® Award Winner in 2025 American Business Awards®
April 29, 2025 02:15 ET | Source: Forbion

Forbion leads €18M Series A Financing in Textile Recycling Technology company EEDEN

Forbion has led the €18 million Series A financing round through its BioEconomy fund of German tech startup EEDEN GmbH.

Next Page keyboard_arrow_right